Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M, Ramió-Pujol S, Serrano M, Amoedo J, Oliver L, Bahí A, Miquel-Cusachs JO, Ramirez M, Queralt-Moles X, Gilabert P, Saló J, Guardiola J, Piñol V, Serra-Pagès M, Castells A, Aldeguer X, Garcia-Gil LJ. Malagón M, et al. Among authors: guardiola j. PLoS One. 2020 Dec 1;15(12):e0243158. doi: 10.1371/journal.pone.0243158. eCollection 2020. PLoS One. 2020. PMID: 33259546 Free PMC article.
Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients.
Rodriguez-Alonso L, Rodriguez-Moranta F, Arajol C, Gilabert P, Serra K, Martin A, Ibáñez-Sanz G, Moreno V, Guardiola J. Rodriguez-Alonso L, et al. Among authors: guardiola j. PLoS One. 2018 Aug 31;13(8):e0203359. doi: 10.1371/journal.pone.0203359. eCollection 2018. PLoS One. 2018. PMID: 30169524 Free PMC article.
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J. Malagón M, et al. Among authors: guardiola j. Aliment Pharmacol Ther. 2019 Jun;49(11):1410-1420. doi: 10.1111/apt.15251. Epub 2019 Apr 25. Aliment Pharmacol Ther. 2019. PMID: 31025420
Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease.
Casellas F, Navarro E, Amil P, Barber C, Marín L, Guardiola J, Espín E, Sainz E, Aldeguer X, Gallego M, Murciano F, García-Planella E, Martín-de-Carpi J, Mendive JM, González-Mestre A. Casellas F, et al. Among authors: guardiola j. Rev Esp Enferm Dig. 2019 Aug;111(8):586-592. doi: 10.17235/reed.2019.6298/2019. Rev Esp Enferm Dig. 2019. PMID: 31317762 Free article.
Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
Pin-Vieito N, Iglesias MJ, Remedios D, Rodríguez-Alonso L, Rodriguez-Moranta F, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Cubiella J, On Behalf Of The Colonpredict Study Investigators. Pin-Vieito N, et al. Among authors: guardiola j. World J Gastroenterol. 2020 Jan 7;26(1):70-85. doi: 10.3748/wjg.v26.i1.70. World J Gastroenterol. 2020. PMID: 31933515 Free PMC article.
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.
Busquets D, Oliver L, Amoedo J, Ramió-Pujol S, Malagón M, Serrano M, Bahí A, Capdevila M, Lluansí A, Torrealba L, Peries L, Chavero R, Gilabert P, Sàbat M, Guardiola J, Serra-Pagès M, Garcia-Gil J, Aldeguer X. Busquets D, et al. Among authors: guardiola j. Inflamm Bowel Dis. 2021 Nov 15;27(Suppl 2):S63-S66. doi: 10.1093/ibd/izab273. Inflamm Bowel Dis. 2021. PMID: 34791288
Definition of a microbial signature as a predictor of endoscopic post-surgical recurrence in patients with Crohn's disease.
Oliver L, Camps B, Julià-Bergkvist D, Amoedo J, Ramió-Pujol S, Malagón M, Bahí A, Torres P, Domènech E, Guardiola J, Serra-Pagès M, Garcia-Gil J, Aldeguer X. Oliver L, et al. Among authors: guardiola j. Front Mol Med. 2023 Feb 3;3:1046414. doi: 10.3389/fmmed.2023.1046414. eCollection 2023. Front Mol Med. 2023. PMID: 39086694 Free PMC article.
433 results